GlassScriptPhysician profile
Brittany Mize
NPI 1053067637
$3,548.91
in general payments reported to CMS, 2019-2025
19 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,804 · 2024: $1,352 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,060 · Travel and Lodging: $1,489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.19 |
| Travel and Lodging | $1,488.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,726.80 | 2023-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $1,173.13 | 2023-2025 | Ams 700 Cxr Rte Kit, Ams 700, General - Erectile Dysfunction |
| Teleflex LLC | $174.33 | 2023-2024 | Urolift |
| Sumitomo Pharma America, INC. | $75.30 | 2023-2025 | Orgovyx, Gemtesa |
| Myriad Genetic Laboratories, INC. | $69.85 | 2024 | Prolaris |
| Laborie Medical Technologies Corp. | $47.65 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $32.88 | 2024 | Balversa, Erleada |
| Medtronic, INC. | $28.79 | 2025 | Interstim |
| Novartis Pharmaceuticals Corporation | $26.26 | 2025 | |
| Endo USA, INC. | $24.55 | 2025 | Xiaflex |
| Verity Pharmaceuticals INC. | $24.40 | 2025 | Tlando |
| Calyxo, INC. | $22.18 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $21.50 | 2025 | |
| Merck Sharp & Dohme LLC | $18.88 | 2023 | Lynparza, Keytruda |
| Antares Pharma, INC. | $18.69 | 2025 | Xyosted |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $17.77 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $16.81 | 2025 | Bard Urinary Drainage Bag |
| Tempus Ai, INC | $14.75 | 2024 | |
| Tolmar, INC. | $14.39 | 2025 | Eligard, Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Mize listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.